High-dose chemotherapy followed by autologous haematopoietic cell transplantation for children, adolescents and young adults with metastatic Ewing sarcoma

To ascertain the efficacy of HDC with AHCT compared with standard-dose chemotherapy in improving event-free survival, overall survival, quality adjusted survival and progression-free survival of children, adolescents and young adults with metastatic ES and to determine their toxicity.

This is a protocol.

Share/Save
Health topics: